EndoGastric Solutions (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced it has secured additional new financing of up to $50.0 million, led by CRG (formerly Capital Royalty L.P.) and existing...
view press release
December 03, 2015, 07:54 AM
|
GenomeDx Biosciences announced it has secured expansion financing from CRG, a premier healthcare investment firm, in the form of a senior secured term loan."We are pleased to have the support of CRG, an investment partner renowned for its strategic...
view press release
September 29, 2015, 07:30 AM
|
Ceterix Orthopaedics has entered into a term loan agreement with CRG (previously known as Capital Royalty L.P.)and certain of its affiliate funds, providing Ceterix with up to $35 million of available borrowing capacity.“We are excited to have...
view press release
May 08, 2015, 07:32 AM
|
Astute Medical, Inc. and CRG announced that Astute recently achieved a milestone under the terms of its existing term loan agreement with CRG. Under the term loan agreement, CRG will provide up to $30 million to support the commercialization of the...
view press release
October 10, 2014, 07:22 AM
|
NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced that it has entered into a term loan agreement with Capital Royalty L.P. and certain of its affiliates. The...
view press release
April 07, 2014, 07:26 AM
|